This content is from: Premium
Pershing Square’s Woes Are a Lot Bigger than Valeant and Herbalife
Bill Ackman’s firm lost 25.6 percent in the first quarter as nearly all its bets went bad — a little or a lot.
William Ackman, Pershing Square (Bloomberg) When you think of William Ackman’s large losses in 2015 and so far this year, you immediately think of his badly timed bet on Valeant Pharmaceuticals International and his long-term, high-profile short of Herbalife. In the case of Valeant, there is good reason. The stock plunged 75
To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.